Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3817-3822

  Ashida, Shingo ^a   Okuda, Heiwa ^a   Chikazawa, Masakazu ^b   Tanimura, Masanobu ^c   Sugita, Osamu ^d   Yamamoto, Yukio ^e   Nakamura, Syoichiro ^f   Moriyama, Masatoshi ^g   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kubokawa Hospital   (Japan)

^c Hata Ken min Hospital   (Japan)

^d Hosogi Hospital   (Japan)

^e Chikamori Hospital   (Japan)

^f KOCHI RED CROSS HOSPITAL   (Japan)

^g Yokohama Citizen Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, RENAL CELL; DNA, COMPLEMENTARY; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIGASES; MALE; MIDDLE AGED; MODELS, GENETIC; MUTATION; NEOPLASM CIRCULATING CELLS; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; RNA; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0033760534     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cellular organ and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, anti-intermediate filament antibodies, and lectins
2. The natural history and clinical features of renal carcinoma
3. Renal cell carcinoma
4. K-ras mutations are found in DNA extracted from the plasma of colorectal cancer patients
5. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
6. Molecular detection of genetic alterations in the serum of colorectal cancer patients
7. Soluble normal and mutated DNA sequences from single copy genes in human blood
8. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
9. Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukemia
10. Mutations of the VHL tumor suppressor gene in renal carcinoma
11. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas
12. Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma
13. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
14. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
15. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma
16. Diagnosis of renal cancer by molecular urinalysis
17. The detection of renal cell carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9
18. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
19. Identification of the von Hippel-Lindau disease tumor suppressor gene
20. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer
21. Effect of no touch isolation on survival and recurrence in curative resections for colorectal cancer